Shares in Indian drug maker Sun Pharmaceutical Industries Ltd rose over 1.8 per cent after its unit received approval from the U.S. Food and Drug Administration for a new drug application to market a generic version of sumatriptan succinate injection. At 10.51 a.m. shares in the company were trading at Rs 496.70,up 1.74 per cent.




